Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
8.8%
% of VHT's 415 holdings also in CANC
70.8%
% of CANC's 48 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 5.4% | 5.4% |
|
MERCK & CO. INC. | 3.3% | 2.7% | 2.7% |
|
AMGEN INC | 2.6% | 2.8% | 2.6% |
|
ABBVIE INC | 4.9% | 1.9% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% | 4.0% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to CANC
|
UNITEDHEALTH GROUP INC | 7.4% |
|
ELI LILLY & CO | 6.6% |
|
JOHNSON & JOHNSON | 5.0% |
|
ABBOTT LABORATORIES | 4.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
ABBVIE INC | 3.0% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
PFIZER INC | 2.2% |
VHT Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.6% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
|
NOVARTIS AG | -4.3% |
 |
ASTRAZENECA PLC | -4.2% |
|
NUVALENT, INC. CLASS A | -3.9% |
|
SUMMIT THERAPEUTICS INC | -3.9% |
|
EXELIXIS INC | -3.7% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
 |
MERUS N.V. | -3.2% |